Kodiak Sciences Inc. (KOD)
NASDAQ
Closed
Oct 9, 2026
Day's Range
93.8952 wk Range
10.94Overview - KOD - Kodiak Sciences Inc.
Key Statistics
Valuation
Enterprise Value
5.63B
P/E (Trailing)
‪-23.14‬
P/E (Forward)
‪-26.51‬
PEG Ratio
‪-11.92‬
Price / Book
‪93.51‬
EV / EBITDA
‪-24.41‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪0.00%‬
Return on Assets
‪-60.44%‬
Return on Equity
‪-368.37%‬
Ownership
Shares Outstanding
62.83M
Float
36.86M
Short % of Shares Outstanding
‪26.87%‬
Held by Insiders
‪5.16%‬
Held by Institutions
‪105.54%‬
Price stats
Beta
‪2.03‬
50-Day Avg
‪45.71‬
200-Day Avg
‪36.31‬
Analyst Consensus
6 analysts
Average price target
‪$ 69.00‬Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - KOD - Kodiak Sciences Inc.
Peers - KOD - Kodiak Sciences Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- KODNASDAQKodiak Sciences Inc.6.27BMarket Cap+88.12%52-week change-23.15P/E (Trailing)‪0.00%‬Profit Margin
- ARGXNASDAQArgenx SE57.50BMarket Cap+14.28%52-week change34.96P/E (Trailing)‪32.26%‬Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals, Inc.29.40BMarket Cap-105.72%52-week change38.35P/E (Trailing)‪16.12%‬Profit Margin
- BNTXNASDAQBioNTech SE American Depositary Share24.34BMarket Cap-8.52%52-week change160.80P/E (Trailing)‪-63.63%‬Profit Margin
- ASNDNASDAQAscendis Pharma A/S14.99BMarket Cap+7.48%52-week change17.72P/E (Trailing)‪70.84%‬Profit Margin
- BBIONASDAQBridgeBio Pharma Inc.13.14BMarket Cap+18.80%52-week change-17.80P/E (Trailing)‪-97.02%‬Profit Margin
- BMRNNASDAQBioMarin Pharmaceutical Inc.11.06BMarket Cap+2.75%52-week change154.54P/E (Trailing)‪2.14%‬Profit Margin
Profile Summary - KOD - Kodiak Sciences Inc.
About
Kodiak Sciences Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for retinal diseases. The company works on treatments for conditions that affect the retina and can lead to vision loss, with a portfolio centered on ophthalmology and retinal vascular disorders. Its current programs…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
